Pyrazole derivatives as 11-beta-HSD1 inhibitors

Details for Australian Patent Application No. 2011232811 (hide)

Owner AstraZeneca AB

Inventors Packer, Martin John; Scott, James Stewart; Stocker, Andrew; Whittamore, Paul Robert Owen

Agent Davies Collison Cave

Pub. Number AU-B-2011232811

Parent 2008215976

Filing date 7 October 2011

Wipo publication date 3 November 2011

Acceptance publication date 31 May 2012

International Classifications

C07D 231/14 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07D 231/18 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

27 October 2011 Complete Application Filed

3 November 2011 Application Open to Public Inspection

  Published as AU-B-2011232811

31 May 2012 Application Accepted

  Published as AU-B-2011232811

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011232812-Carbon dioxide separation recovery system and method of measuring amount of reboiler input heat

2011232810-Polymers with antimicrobial activity containing quaternary ammonium groups